Key facts
- This page summarizes Alset International Ltd's Form 3 filing for DSS, INC. (DSS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2022, 20:39.
Alset International Ltd - 12 Jul 2022 Form 3 Insider Report for DSS, INC. (DSS)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- DSS
- Reported as of
- 12 Jul 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Alset International Limited by Heng Fai Ambrose Chan
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Alset International Ltd filed Form 3 for DSS, INC. (DSS) on 14 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DSS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 21,366,177
- Date
- 12 Jul 2022
- Ownership
- Direct
- Footnotes
- F1
DSS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,232,671
- Date
- 12 Jul 2022
- Ownership
- See Footnote
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
21,366,177 shares of the common stock of DSS, Inc. (the "Issuer") are held directly by Alset International Limited ("AIL"). These shares were acquired on July 12, 2022 pursuant to an assignment and assumption agreement (the "Agreement") between the Issuer and AIL dated February 28, 2022, as amended on July 12, 2022. Pursuant to the Agreement, as amended, the Issuer agreed to purchase a convertible promissory note from AIL (the "Note"). The Note has a principal amount of $8,350,000 and accrued but unpaid interest of $367,400. The Note was issued by American Medical REIT, Inc., a Maryland corporation. The consideration paid for the Note was 21,366,177 shares of the Issuer's common stock. The consideration was calculated by dividing $8,717,400, the aggregate of the principal amount and the accrued but unpaid interest under the Note, by $0.408 per share.
Footnote F2
6,232,671 shares of the common stock of the Issuer are held by Global Biomedical Pte. Ltd., a subsidiary of AIL.